Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1995 Feb;58(2):215–217. doi: 10.1136/jnnp.58.2.215

Pholedrine: a substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner's syndrome.

A T Bates 1, S Chamberlain 1, M Champion 1, L Foley 1, E Hughes 1, B Jani 1, H Mehta 1, S E Smith 1
PMCID: PMC1073320  PMID: 7876854

Abstract

Mydriatic responses to eyedrops containing the indirect acting sympathomimetic amines tyramine, hydroxyamphetamine, and pholedrine have been compared in 10 healthy subjects. Pholedrine, the n-methyl derivative of hydroxyamphetamine, at a concentration of 1% had effects similar to those produced by 0.5% hydroxyamphetamine itself. Pretreatment with topical guanethidine attenuated its responses and in 13 patients with unilateral Horner's syndrome it distinguished clearly those five patients who had preganglionic from the eight with postganglionic lesions. It is concluded that 1% pholedrine may be substituted for 0.5% hydroxyamphetamine, which is no longer available, as a diagnostic agent for use in Horner's syndrome.

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burde R. M., Thompson H. S. Hydroxyamphetamine. A good drug lost? Am J Ophthalmol. 1991 Jan 15;111(1):100–102. doi: 10.1016/s0002-9394(14)76904-1. [DOI] [PubMed] [Google Scholar]
  2. Cremer S. A., Thompson H. S., Digre K. B., Kardon R. H. Hydroxyamphetamine mydriasis in Horner's syndrome. Am J Ophthalmol. 1990 Jul 15;110(1):71–76. doi: 10.1016/s0002-9394(14)76941-7. [DOI] [PubMed] [Google Scholar]
  3. Maloney W. F., Younge B. R., Moyer N. J. Evaluation of the causes and accuracy of pharmacologic localization in Horner's syndrome. Am J Ophthalmol. 1980 Sep;90(3):394–402. doi: 10.1016/s0002-9394(14)74924-4. [DOI] [PubMed] [Google Scholar]
  4. Smith S. E., Smith S. A., Brown P. M., Fox C., Sönksen P. H. Pupillary signs in diabetic autonomic neuropathy. Br Med J. 1978 Sep 30;2(6142):924–927. doi: 10.1136/bmj.2.6142.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Sneddon J. M., Turner P. The interactions of local guanethidine and sympathomimetic amines in the human eye. Arch Ophthalmol. 1969 May;81(5):622–627. doi: 10.1001/archopht.1969.00990010624005. [DOI] [PubMed] [Google Scholar]
  6. Wilhelm H., Ochsner H., Kopycziok E., Trauzettel-Klosinski S., Schiefer U., Zrenner E. Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol. 1992;1(2):96–102. [PubMed] [Google Scholar]
  7. Wilhelm H., Schäffer E. Pholedrin zur Lokalisation des Horner-Syndroms. Klin Monbl Augenheilkd. 1994 Mar;204(3):169–175. doi: 10.1055/s-2008-1035515. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES